Nanjing Vishee Medical Technology Co., Ltd

Shanghai Stock Exchange 688580.SS

Nanjing Vishee Medical Technology Co., Ltd Price to Sales Ratio (P/S) on January 14, 2025: 5.49

Nanjing Vishee Medical Technology Co., Ltd Price to Sales Ratio (P/S) is 5.49 on January 14, 2025, a -36.03% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Nanjing Vishee Medical Technology Co., Ltd 52-week high Price to Sales Ratio (P/S) is 8.70 on January 16, 2024, which is 58.50% above the current Price to Sales Ratio (P/S).
Nanjing Vishee Medical Technology Co., Ltd 52-week low Price to Sales Ratio (P/S) is 4.31 on September 18, 2024, which is -21.38% below the current Price to Sales Ratio (P/S).
Nanjing Vishee Medical Technology Co., Ltd average Price to Sales Ratio (P/S) for the last 52 weeks is 6.12.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Shanghai Stock Exchange: 688580.SS

Nanjing Vishee Medical Technology Co., Ltd

CEO	Mr. Zhiyu Wang
IPO Date	July 21, 2020
Location	China
Headquarters	No. 19, Ningshuang Road
Employees	700
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Nanjing Vishee Medical Technology Co., Ltd. develops and manufactures medical rehabilitation devices in China. It offers pelvic floor and postpartum, neurological, and mental rehabilitation solutions; and bio-stimulation feedback devices, magnetic stimulators, etc. The company's solutions cover markets, such as electrical and magnetic stimulation, electrophysiology, and other technical directions. It offers its products through dealers, sales network, and distributors to hospitals, and terminal medical and professional institutions. The company was founded in 2001 and is based in Nanjing, China.

Key trends

Past 5 years